(Q51541835)

6 April 2018

title

SEOM guidelines for the treatment of malignant pleural mesothelioma. (English)

1 reference

6 April 2018

author name string

Pilar Lianes

1

1 reference

6 April 2018

Jordi Remon

2

1 reference

6 April 2018

Isabel Bover

3

1 reference

6 April 2018

Dolores Isla

4

1 reference

6 April 2018

publication date

1 August 2011

1 reference

6 April 2018

Clinical and Translational Oncology

published in

1 reference

6 April 2018

volume

13

1 reference

6 April 2018

issue

8

1 reference

6 April 2018

page(s)

569-573

1 reference

6 April 2018

Malignant pleural mesothelioma: an update on biomarkers and treatment

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS12094-011-0699-5

Malignant pleural mesothelioma: the standard of care and challenges for future management

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-011-0699-5

Guidelines of the European Respiratory Society and the European Society of Thoracic Surgeons for the management of malignant pleural mesothelioma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-011-0699-5

Neoadjuvant and intrapleural therapies for malignant pleural mesothelioma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-011-0699-5

Extrapleural pneumonectomy versus pleurectomy/decortication in the surgical management of malignant pleural mesothelioma: results in 663 patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-011-0699-5

Radiotherapy in malignant pleural mesothelioma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-011-0699-5

Multimodality strategies in malignant pleural mesothelioma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-011-0699-5

Resection margins, extrapleural nodal status, and cell type determine postoperative long-term survival in trimodality therapy of malignant pleural mesothelioma: results in 183 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-011-0699-5

A randomised trial in malignant mesothelioma (M) of early (E) versus delayed (D) chemotherapy in symptomatically stable patients: the MED trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-011-0699-5

Second-line (post-study) chemotherapy received by patients treated in the phase III trial of pemetrexed plus cisplatin versus cisplatin alone in malignant pleural mesothelioma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-011-0699-5

Mesothelin-family proteins and diagnosis of mesothelioma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-011-0699-5

Malignant pleural mesothelioma

21 January 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/21821492

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Modified RECIST criteria for assessment of response in malignant pleural mesothelioma

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/21821492

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1007/S12094-011-0699-5

1 reference

6 April 2018

1 reference

6 April 2018